UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

____________________

 

FORM 8-K

____________________

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): March 27, 2017

____________________

 

GLOBAL MEDICAL REIT INC.
(Exact name of registrant as specified in its charter)

____________________

 

Maryland 8091371022 46-4757266
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
     
 

4800 Montgomery Lane, Suite 450

Bethesda, MD

20814

 
  (Address of Principal Executive Offices)
(Zip Code)
 
     
  (202) 524-6851  
(Registrant’s Telephone Number, Including Area Code)

____________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

Item 2.02  Results of Operations and Financial Condition.

 

On March 27, 2017, Global Medical REIT Inc. (the “Company”) issued a press release announcing the Company’s operating results for its fourth quarter and fiscal year ended December 31, 2016. A copy of the press release has been furnished as Exhibit 99.1 to this Current Report, and is incorporated herein by reference.

 

The information included in this Current Report, including the exhibit related hereto, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)  Exhibits

 

Exhibit No.   Description
99.1   Press release dated March 27, 2017

 

2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GLOBAL MEDICAL REIT INC.
     
     
  By: /s/ Conn Flanigan
    Conn Flanigan
    Secretary and General Counsel

 

Dated: March 27, 2017

 

3 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1  

Press release dated March 27, 2017

 

  

4